Professor Nicholas Harvey, Professor of Rheumatology and Clinical Epidemiology at the MRC Lifecourse Epidemiology Unit (MRC LEU), University of Southampton, and Honorary Consultant Rheumatologist, University Hospital Southampton, has been appointed as a Clinical Trustee of the UK Royal Osteoporosis Society (ROS, formerly the National Osteoporosis Society). Prof Harvey, who also serves as Vice-Chair of the International Osteoporosis Foundation’s Committee of Scientific Advisers, Vice-Chair of the ROS Osteoporosis and Bone Research Academy, and as a member of the American Society for Bone and Mineral Research Professional Practice Committee, said

“It is a huge honour to be afforded the privilege of serving as part of the Royal Osteoporosis Society Board of Trustees. The ROS is the U.K.’s foremost clinical society focused on osteoporosis and metabolic bone disease, and over recent decades has made enormous contributions to the advancement of patient care and research in our field. I very much look forward to working with the society, both as a member of the Board of Trustees, and as part of the leadership of the Bone Research Academy, to advance this mission over coming years.”

Professor Cyrus Cooper, Director and Professor of Rheumatology, MRC LEU, University of Southampton, President of the International Osteoporosis Foundation, and a past Chair of the National Osteoporosis Society Board of Trustees, commented,

“My sincere congratulations to Professor Harvey on his appointment to this prestigious national post. Professor Harvey has already contributed widely to the field working with the Royal Osteoporosis Society and Bone Research Society in the UK, with additional leadership roles in the International Osteoporosis Foundation and American Society for Bone and Mineral Research. His appointment to the ROS Board of Trustees will provide fantastic new opportunities to consolidate such links, in order to optimise the health of patients with osteoporosis, through advances in research, clinical care and policy.”